
Artos AI is a Y Combinator company that provides an AI-powered platform for document creation and management specifically for the life sciences industry. Their solution aims to help biopharma companies bring products to market faster and more cost-effectively by streamlining the regulatory submission process. The platform offers an end-to-end suite for the entire CTD pyramid, from raw data to final draft, with features like document drafting, downstream visualization, and source traceability. Artos is designed to cater to the unique needs of various teams within life sciences organizations, including medical writing, CMC, regulatory affairs, and engineering, by providing specialized tools for document lifecycle management, data transformation, and AI system deployment. The company emphasizes collaboration and provides resources for security, legal practices, and integrations to ensure regulatory excellence and high-quality AI.

Artos AI is a Y Combinator company that provides an AI-powered platform for document creation and management specifically for the life sciences industry. Their solution aims to help biopharma companies bring products to market faster and more cost-effectively by streamlining the regulatory submission process. The platform offers an end-to-end suite for the entire CTD pyramid, from raw data to final draft, with features like document drafting, downstream visualization, and source traceability. Artos is designed to cater to the unique needs of various teams within life sciences organizations, including medical writing, CMC, regulatory affairs, and engineering, by providing specialized tools for document lifecycle management, data transformation, and AI system deployment. The company emphasizes collaboration and provides resources for security, legal practices, and integrations to ensure regulatory excellence and high-quality AI.
What they do: AI-powered document creation and management platform for life sciences (regulatory and R&D submissions)
Founded: 2023
Stage / Funding: Pre-seed (reported round on 2024-02-27); investors include Y Combinator and Pioneer Fund
Team size: ~12 employees
Regulatory document authoring and lifecycle management for life sciences organizations.
2023
Biotechnology Research
500000
Investors reported include Y Combinator and Pioneer Fund
“Backed by Y Combinator and Pioneer Fund”
| Company |
|---|